The company’s investigational new drug paxalisib is being developed to treat glioblastoma (GBM), an...
Emerald Clinics hits record number of patients; joins global fight against COVID-19
Kazia Therapeutics sees 2020 as crucial inflection point for oncology programs
eSense-Lab in binding JV for new range of skincare, hair care and hand sanitisers using terpenes
Only registered members can use this feature.
Copyright © Proactive Investors 2020.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.